Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany.
Small Animal Clinic, University of Veterinary Medicine Hannover, Hannover, Germany.
Vet Anaesth Analg. 2024 May-Jun;51(3):244-252. doi: 10.1016/j.vaa.2024.02.001. Epub 2024 Feb 9.
To evaluate the effect of oral tasipimidine on dog handling, ease of catheter placement and propofol and isoflurane requirements for anaesthesia.
Placebo-controlled, randomized, blinded, experimental trial.
A group of seven adult Beagle dogs weighing (mean ± standard deviation) 13.1 ± 2.7 kg with a mean age of 18.6 ± 1 months.
The dogs underwent four treatments before induction of anaesthesia with propofol. PP: placebo orally (PO) 60 minutes before induction of anaesthesia followed by placebo (NaCl 0.9%) intravenously (IV). TP: tasipimidine 30 μg kg (PO) 60 minutes before induction of anaesthesia followed by placebo (NaCl 0.9%) IV. TMP: tasipimidine 30 μg kg PO 60 minutes before induction of anaesthesia followed by methadone 0.2 mg kg IV. TMPD: tasipimidine 30 μg kg PO 60 minutes before induction of anaesthesia followed by methadone 0.2 mg kg and dexmedetomidine 1 μg kg IV followed by a dexmedetomidine constant rate infusion of 1 μg kg hour. Sedation, response to catheter placement, intubation quality, time to loss of consciousness, time to intubation, required dose of propofol and minimum alveolar isoflurane concentration preventing motor movement (MAC) were determined. A mixed-model analysis or the Friedman and Mann-Whitney test were used; p-value < 0.05.
Response to catheter placement did not differ between treatments. Tasipimidine alone reduced the propofol dose by 30%. Addition of methadone or methadone and dexmedetomidine reduced the propofol dose by 48% and 50%, respectively. Isoflurane MAC was reduced by 19% in tasipimidine-medicated dogs, whereas in combination with methadone or methadone and dexmedetomidine, isoflurane MAC was reduced by 35%.
An anxiolytic dose of tasipimidine induced mild signs of sedation in dogs and reduced propofol and isoflurane requirements to induce and maintain anaesthesia, which needs to be considered in an anaesthetic plan.
评估口服他匹嘧啶对犬类操作、导管放置的简易程度以及丙泊酚和异氟醚麻醉需求的影响。
安慰剂对照、随机、双盲、实验性试验。
一组 7 只成年比格犬,体重(均值±标准差)为 13.1±2.7kg,平均年龄为 18.6±1 个月。
在丙泊酚诱导麻醉前,这些犬接受了四种处理。PP:麻醉诱导前 60 分钟口服安慰剂(PO),然后静脉注射生理盐水(0.9%NaCl)。TP:麻醉诱导前 60 分钟口服他匹嘧啶 30μg/kg,然后静脉注射生理盐水(0.9%NaCl)。TMP:麻醉诱导前 60 分钟口服他匹嘧啶 30μg/kg,然后静脉注射美沙酮 0.2mg/kg。TMPD:麻醉诱导前 60 分钟口服他匹嘧啶 30μg/kg,然后静脉注射美沙酮 0.2mg/kg 和右美托咪定 1μg/kg,然后持续静脉输注右美托咪定 1μg/kg/h。确定镇静、导管放置反应、插管质量、意识丧失时间、插管时间、所需丙泊酚剂量以及防止运动的最小肺泡异氟醚浓度(MAC)。采用混合模型分析或 Friedman 和 Mann-Whitney 检验;p 值<0.05。
处理之间对导管放置的反应没有差异。单独使用他匹嘧啶可使丙泊酚剂量减少 30%。美沙酮或美沙酮加右美托咪定的添加可使丙泊酚剂量分别减少 48%和 50%。他匹嘧啶给药犬的异氟醚 MAC 降低 19%,而与美沙酮或美沙酮加右美托咪定联合使用时,异氟醚 MAC 降低 35%。
在犬类中,使用抗焦虑剂量的他匹嘧啶可引起轻微的镇静迹象,并减少诱导和维持麻醉所需的丙泊酚和异氟醚用量,这在麻醉计划中需要考虑。